Kezar Life Sciences Announces Formation of Clinical Advisory Committee
Kezar Presents Results of the Completed MISSION Phase 1b Study of KZR-616 at EULAR 2021
Kezar Appoints Rheumatology Industry Expert, Micki Klearman, MD, to its Board of Directors
Kezar Life Sciences to Participate in the Jefferies Virtual Healthcare Conference
Kezar Life Sciences to Host Virtual MISSION Phase 1b Data Update Call at EULAR 2021 on June 2, 2021
